Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C

Clinical Immunology

Volumn 97, Issue 2, 2000, Pages 146-153

  Tacket, Carol O ^a   Galen, James ^a   Sztein, Marcelo B ^a   Losonsky, Genevieve ^a   Wyant, Timothy L ^a   Nataro, James ^a   Wasserman, Steven S ^a   Edelman, Robert ^a   Chatfield, Stephen ^b   Dougan, Gordon ^c   Levine, Myron M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Medeva Group Research   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Human volunteers; Immunogenicity; Oral; Safety; Salmonella Typhi; Tetanus; Vaccines

Indexed keywords

BICARBONATE; CVD 908 HTRA; CVD 908 HTRA(PEPNIR 15); CVD 908 HTRA(PTETLPP); TETANUS TOXIN; TETANUS TOXOID; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALMONELLA ENTERICA; STRAIN DIFFERENCE; VACCINATION; VOMITING;

EID: 0033781547     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4924     Document Type: Article

References (19)

1. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans
2. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans
3. Phase 2 clinical trial of attenuated Salmonella typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers
4. Demonstration of specific IgA in human feces after immunization with line Ty21a Salmonella typhi vaccine
5. Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine
6. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans
7. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi
8. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine
9. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to foreign antigens
10. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain
11. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella typhi as live mucosal vaccines and as live vectors
12. Effect of priming with carrier on response to conjugate vaccine
13. Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells
14. Optimization of plasmid maintenance in the attenuated live vector vaccine Salmonella typhi strain CVD 908-htrA
15. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium
16. Oral vaccination against tetaus: Comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters
17. Optimism over vaccines administered via mucosal surfaces
18. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing words: Model based regional estimates
19. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and non-infected adults in Mali